Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 8.93 Million AUD | 19.55% |
| 2023 | 7.47 Million AUD | 32.85% |
| 2022 | 5.62 Million AUD | 45.25% |
| 2021 | 3.87 Million AUD | 71.64% |
| 2020 | 2.25 Million AUD | 16.28% |
| 2019 | 1.94 Million AUD | -60.92% |
| 2018 | 4.96 Million AUD | -44.61% |
| 2017 | 8.96 Million AUD | 22.66% |
| 2016 | 7.31 Million AUD | 34.67% |
| 2015 | 5.42 Million AUD | 32.8% |
| 2014 | 4.08 Million AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.56 Million AUD | 103.91% |
| 2024 FY | 8.93 Million AUD | 19.55% |
| 2024 Q1 | 1.74 Million AUD | -36.45% |
| 2024 Q4 | 5.37 Million AUD | 0.0% |
| 2023 FY | 7.47 Million AUD | 32.85% |
| 2023 Q2 | 4.64 Million AUD | 100.78% |
| 2023 Q3 | 1.26 Million AUD | -72.73% |
| 2023 Q4 | 2.75 Million AUD | 117.05% |
| 2023 Q1 | 2.31 Million AUD | -34.58% |
| 2022 Q4 | 3.54 Million AUD | 0.0% |
| 2022 FY | 5.62 Million AUD | 45.25% |
| 2022 Q2 | 2.08 Million AUD | 0.0% |
| 2021 Q4 | 2.44 Million AUD | 0.0% |
| 2021 Q2 | 1.42 Million AUD | 0.0% |
| 2021 FY | 3.87 Million AUD | 71.64% |
| 2020 Q4 | 1.36 Million AUD | 0.0% |
| 2020 FY | 2.25 Million AUD | 16.28% |
| 2020 Q2 | 888.53 Thousand AUD | 0.0% |
| 2019 FY | 1.94 Million AUD | -60.92% |
| 2018 FY | 4.96 Million AUD | -44.61% |
| 2017 FY | 8.96 Million AUD | 22.66% |
| 2016 FY | 7.31 Million AUD | 34.67% |
| 2015 FY | 5.42 Million AUD | 32.8% |
| 2014 FY | 4.08 Million AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 89.703% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -81.717% |
| SQZ Biotechnologies Company | 85.61 Million USD | 89.562% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 69.761% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 76.013% |
| Mesoblast Limited | 5.9 Million USD | -51.418% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -495.024% |
| Genus plc | 147.7 Million USD | 93.949% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -1.793% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -566.147% |
| Marizyme, Inc. | 19.23 Million USD | 53.551% |
| ContraFect Corporation | 56.88 Million USD | 84.291% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -7.167% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -102.707% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -504.338% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -206.445% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -220.27% |
| MultiCell Technologies, Inc. | 567.42 USD | -1574864.929% |
| Accustem Sciences Inc. | 3.74 Million USD | -138.539% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 89.602% |
| EV Biologics, Inc. | 531.96 Thousand USD | -1579.944% |
| Q BioMed Inc. | 3.43 Million USD | -160.042% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 63.841% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -2194.006% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -240.118% |
| Biomind Labs Inc. | 994.18 Thousand USD | -798.896% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 96.037% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -33.025% |
| Skye Bioscience, Inc. | 13.54 Million USD | 34.035% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -336.21% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 35846.664% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -77.243% |
| IMV Inc. | 37.7 Million USD | 76.301% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 44.182% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -386.987% |
| GB Sciences, Inc. | 1.42 Million USD | -529.117% |
| Alpha Cognition Inc. | 9.7 Million USD | 7.923% |
| HST Global, Inc. | 140.9 Thousand USD | -6242.244% |
| CSL Limited | 3.44 Billion USD | 99.741% |
| Halberd Corporation | 74.84 Thousand USD | -11840.71% |
| Enzolytics Inc. | 2.17 Million USD | -310.032% |
| Resverlogix Corp. | 12.71 Million USD | 29.699% |
| Affymax, Inc. | 39.38 Million USD | 77.31% |
| SYBLEU INC | 160.87 Thousand USD | -5455.003% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -144.793% |
| argenx SE | 1.53 Billion USD | 99.417% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 84.442% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -756.002% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -465.843% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -162.459% |
| AVAX Technologies, Inc. | 7.31 Million USD | -22.248% |
| Zenith Capital Corp. | 8.94 Million USD | 0.071% |
| Genscript Biotech Corporation | 825.34 Million USD | 98.917% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -51198.238% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -263.972% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -5110.611% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 91.003% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -407.858% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | -353.17% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -379.34% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 17.763% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -365.232% |
| BioStem Technologies, Inc. | 22.97 Million USD | 61.102% |
| ONE Bio Corp. | 6.44 Million USD | -38.684% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -4824.19% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -569.197% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -694.434% |
| Agentix Corp. | 1.37 Million USD | -551.476% |
| LadRx Corporation | 3.81 Million USD | -134.448% |
| Cell Source, Inc. | 4.32 Million USD | -106.612% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -2050.931% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -867.685% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -867.685% |
| NovAccess Global Inc. | 2.46 Million USD | -262.283% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -271.597% |
| Itoco Inc. | 919.14 Thousand USD | -872.282% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -110.849% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -698.63% |
| Kadimastem Ltd | 2.41 Million USD | -270.799% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -3314.512% |
| CytoDyn Inc. | 18.05 Million USD | 50.511% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -35406.639% |
| Mobile Lads Corp. | 554.54 Thousand USD | -1511.528% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -3960.681% |
| Qrons Inc. | 643.67 Thousand USD | -1288.377% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -529.435% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -300.769% |
| Rebus Holdings, Inc. | 664 Thousand USD | -1245.883% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -392.02% |
| International Stem Cell Corporation | 5.27 Million USD | -69.544% |
| Bioxytran, Inc. | 3.82 Million USD | -133.935% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -16876.304% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -43829.932% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 75.358% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -452.328% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -1114.493% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -187.26% |
| Neutra Corp. | 243.82 Thousand USD | -3565.257% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 48.808% |
| PureTech Health plc | 144.59 Million USD | 93.82% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 56.385% |
| IXICO plc | 4.7 Million USD | -89.859% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -1.588% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 92.41% |
| CSL Limited | 3.89 Billion USD | 99.77% |
| Cellectis S.A. | 97.32 Million USD | 90.817% |